Focused on discovery and optimization challenges of small molecule drug candidates, Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech.

Final Agenda Now Available Drug Discovery Chemistry is a dynamic conference for medicinal and biophysical chemists working in pharma, biotech, and academia. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's personal interests by going back and forth among concurrent tracks. New for 2023 is coverage of targeting transcription factors, plus greatly expanded coverage of protein degraders, molecular glues, and artificial intelligence for early drug discovery. Speakers from industry will once again be strongly represented, including: AbbVie, Amgen, Astex Pharmaceuticals, AstraZeneca, Biogen, Bristol Myers Squibb, EMD Serono, Genentech, GlaxoSmithKline, Janssen, Johnson & Johnson, Merck, Novartis, Pfizer, and more. In addition, featured presentations will be given by the University of Washington's David Baker, Stanford's Gerald Crabtree, Vanderbilt's Stephen Fesik, and UC Berkeley's Daniel Nomura. For maximum savings, reserve your place by March 3. Bring a team to San Diego and save 25% with a Group registration

Read on cii.dryfta.com

Continue reading at drugdiscoverychemistry.com

Bioengineers and Biomedical Engineers Biochemists and Biophysicists Bioengineering

Facebook Share

Twitter Share

Linkedin Share

Email Share